Bristol Myers Squibb ROI - Return on Investment 2010-2024 | BMY
- Bristol Myers Squibb average return on investment for 2023 was 11.89, a 32.11% decline from 2022.
- Bristol Myers Squibb average return on investment for 2022 was 9, a 432.1% increase from 2021.
- Bristol Myers Squibb average return on investment for 2021 was -2.71, a 16.31% decline from 2020.
Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.